搜索
Viatris Inc
VTRS添加自选
15.370USD
-0.360-2.29%
收盘 06/18, 16:00（美东）报价延迟15分钟
17.90B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Davis Selected Advisers, L.P.
6.72%
T. Rowe Price Associates, Inc.
6.64%
Vanguard Capital Management, LLC
6.42%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.75%
其他
70.15%
持股股东
持股股东
占比
Davis Selected Advisers, L.P.
6.72%
T. Rowe Price Associates, Inc.
6.64%
Vanguard Capital Management, LLC
6.42%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.75%
其他
70.15%
股东类型
持股股东
占比
Investment Advisor
42.37%
Investment Advisor/Hedge Fund
29.03%
Hedge Fund
9.64%
Research Firm
2.91%
Pension Fund
1.34%
Bank and Trust
0.75%
Sovereign Wealth Fund
0.55%
Individual Investor
0.30%
Family Office
0.07%
其他
13.05%
机构持股
更新时间: 4月5日 周日
更新时间: 4月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2026Q1
1992
1.01B
86.70%
-70.29M
2025Q4
1961
1.01B
87.56%
-51.34M
2025Q3
1934
987.12M
85.35%
-46.41M
2025Q2
1947
984.91M
83.97%
-87.31M
2025Q1
2006
1.01B
85.93%
-61.76M
2024Q4
2002
1.03B
86.53%
+1.20M
2024Q3
1949
989.28M
82.89%
-66.19M
2024Q2
1967
1.02B
85.33%
-16.59M
2024Q1
1986
997.86M
84.00%
-35.39M
2023Q4
2032
990.53M
82.57%
-31.15M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Davis Selected Advisers, L.P.
78.18M
6.79%
+8.83M
+12.74%
Dec 31, 2025
T. Rowe Price Associates, Inc.
77.29M
6.71%
-4.89M
-5.95%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
62.10M
5.39%
+940.67K
+1.54%
Dec 31, 2025
State Street Investment Management (US)
55.31M
4.8%
-397.21K
-0.71%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
40.03M
3.48%
+2.66M
+7.11%
Dec 31, 2025
Geode Capital Management, L.L.C.
31.11M
2.7%
+1.19M
+3.98%
Dec 31, 2025
Columbia Threadneedle Investments (US)
26.09M
2.27%
-1.36M
-4.96%
Dec 31, 2025
Rubric Capital Management LP
25.50M
2.21%
+10.12M
+65.75%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares U.S. Pharmaceuticals ETF
4.46%
First Trust NASDAQ Pharmaceuticals ETF
3.81%
Davis Select Worldwide ETF
3.62%
Davis Select US Equity ETF
3.36%
Invesco Pharmaceuticals ETF
2.66%
State Street SPDR S&P Pharmaceuticals ETF
2.64%
Invesco S&P Ultra Dividend Revenue ETF
2.56%
Alps Sector Dividend Dogs ETF
2.1%
AAM S&P 500 High Dividend Value ETF
1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.88%
查看更多
iShares U.S. Pharmaceuticals ETF
占比4.46%
First Trust NASDAQ Pharmaceuticals ETF
占比3.81%
Davis Select Worldwide ETF
占比3.62%
Davis Select US Equity ETF
占比3.36%
Invesco Pharmaceuticals ETF
占比2.66%
State Street SPDR S&P Pharmaceuticals ETF
占比2.64%
Invesco S&P Ultra Dividend Revenue ETF
占比2.56%
Alps Sector Dividend Dogs ETF
占比2.1%
AAM S&P 500 High Dividend Value ETF
占比1.95%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.88%
